about
Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysisAzathioprine and UVA light generate mutagenic oxidative DNA damageExpert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UKExploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosisMicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell CarcinomaWhole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell Carcinoma.Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for identification of cutaneous wart-associated human papillomavirus types.iASPP/p63 autoregulatory feedback loop is required for the homeostasis of stratified epithelia.Recurrent mutations in kindlin-1, a novel keratinocyte focal contact protein, in the autosomal recessive skin fragility and photosensitivity disorder, Kindler syndrome.AKT1 loss correlates with episomal HPV16 in vulval intraepithelial neoplasia.Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective.Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers.No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma.Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individualsKey differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling.Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation.NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesisp63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy.Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness.Vulval intraepithelial neoplasia and periungual Bowen's disease concordant for mucosal (HPV-34) and epidermodysplasia verruciformis (HPV-21) human papillomavirus typesKeratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy.Genital and cutaneous human papillomavirus (HPV) types in relation to conjunctival squamous cell neoplasia: a case-control study in Uganda.PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients.The seroprevalence of human papillomavirus by immune status and by ethnicity in London.Carcinogenic mechanisms related to immunosuppressive therapy.Appendageal malignancies.BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel.p53 codon 72 polymorphism and risk of cervical cancer in UK.The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma.Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas.Long-term topical corticosteroid use and risk of skin cancer: a systematic review protocol.Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma.The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling.Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series.Painful skin lesions and squamous cell carcinoma predict overall mortality risk in organ transplant recipients: a cohort study.Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment.Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinomaCauses and clinical manifestations of lymphatic failure.
P50
Q24657188-16AD42EF-D3E9-479C-8AE1-003B86FE7ECCQ24657288-C345AAA5-819A-4454-8EC6-7A23C3F39ADFQ26799390-FB768D2D-2A29-4F35-AD46-BC9654714FC4Q28276344-52431C01-7F2B-48CF-8F2C-738AF2D6D9C0Q28546971-A08BD6BF-309D-48C0-A6F3-EED02CA88BA5Q33614146-66D16A6F-7D65-4BA5-B64F-600F52E4E8A1Q33827009-CB0536A2-D186-4B8C-8AC7-582C915636BEQ34214054-10A17B36-7FA8-49F9-A948-DC2CCB316A52Q34298513-B3E90335-905A-4987-AC40-DD1A573C8982Q34299690-EE68D2A4-EC47-4C8E-A5D4-B0374598A032Q34354492-6EDDB512-F14C-4978-9329-E3C6F1EC436AQ34429330-D54DE61B-6744-4F75-89A2-BA82FB077DD9Q34591340-D7AB4A91-EA08-497A-8224-02B779FA024CQ34591357-E6A386C4-9650-4B42-9390-125F09550A91Q35066454-00CB53AE-A371-417C-AA04-27119847B270Q36134453-4D4895AE-819A-47C2-8AA4-D69AEABB90FAQ36580224-068383FA-D7EF-4BCF-B9FF-98C87452571FQ36694173-FC463ADE-5B27-4AF0-B47F-AA8C713B93A6Q36711033-89A2DB76-5AD9-40F9-9071-BF8986932D28Q36711044-03A98CF9-978E-4419-BF22-43F2FE4664E4Q36711048-90E46111-A542-45F0-9D24-78F1FE698AFDQ36782544-9F9BE60D-498E-421B-9829-79EE82A68254Q36906084-C295478C-DB67-4E22-B057-E50F93405521Q36944052-DF16A7AF-86E4-4CBD-A41B-0AE037BCD156Q37384066-87FD4723-B79C-4381-946C-DC5ED4E3C1F8Q37470054-EFCF0522-33F1-4928-9A44-5F0E95D4C8E8Q37470146-67FD8266-E50F-4BB4-A50A-788BBAFBCC24Q38077556-4BE77737-714D-417F-85F9-EF2022A8171AQ38470977-EB14BC3A-214B-4837-86DE-53F66633566AQ38530398-0BDE9090-8B44-43C6-BFF4-C9CF11437756Q38684394-0F99538B-A0E1-4E69-AE02-36DBEA05D705Q39051589-890E0B8C-50A3-4018-982E-C9A780E967DAQ39195005-33B69EDE-F9DB-4BD1-97FC-3E87BD20DE92Q39297991-94EF3A38-4133-4F49-B287-2A8D4219ADD8Q40354945-9E75FAEF-582A-420D-BF2D-D27CB2F15490Q40396783-70B3F2FD-AEA6-457D-BA34-FD5FEB7A7BAAQ40760209-53A7AE10-A4A0-4079-B2B6-8F5B4D8B8330Q40779960-1A94691C-C7E3-47EC-9A5B-005A3B6F58DBQ40989877-4287CCE0-1155-4814-AB98-53AB6F3A9983Q41006066-562964E8-C612-41C1-A18B-68E1D5734457
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Catherine Harwood
@ast
Catherine Harwood
@en
Catherine Harwood
@es
Catherine Harwood
@nl
type
label
Catherine Harwood
@ast
Catherine Harwood
@en
Catherine Harwood
@es
Catherine Harwood
@nl
prefLabel
Catherine Harwood
@ast
Catherine Harwood
@en
Catherine Harwood
@es
Catherine Harwood
@nl
P106
P21
P31
P496
0000-0002-1375-0965